Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NNMT | P40261 | 18/20 | 0.46 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.44 |
| ▸ | WDR77 | Q9BQA1 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19667617 | 0.85 | PRMT5 (0.48) | NNMTPRMT5WDR77 | |
| SCHEMBL19667138 | 0.82 | NNMT (0.38) | NNMTPRMT5WDR77 | |
| SCHEMBL30941419 | 0.82 | PRMT5 (0.47) | NNMTPRMT5WDR77 | |
| SCHEMBL20873479 | 0.82 | PRMT5 (0.47) | NNMTPRMT5WDR77 | |
| SCHEMBL21367288 | 0.78 | PRMT5 (0.46) | PRMT5WDR77 | |
| SCHEMBL18571708 | 0.77 | PRMT5 (0.51) | NNMTPRMT5WDR77 | |
| SCHEMBL21683023 | 0.73 | PRMT5 (0.35) | NNMTPRMT5WDR77 | |
| SCHEMBL22002025 | 0.73 | AHCY (0.52) | NNMTPRMT5WDR77 | |
| SCHEMBL18572585 | 0.73 | AHCY (0.52) | NNMTPRMT5WDR77 | |
| SCHEMBL9109736 | 0.73 | AHCY (0.52) | NNMTPRMT5WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220152073-A1 | Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5) | PRELUDE THERAPEUTICS INCORPORATED | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220152073-A1 | Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5) | PRMT5, PRMT1, PRMT6 | NNMT 19/4885PRMT5 1/4885WDR77 57/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.